At a glance
- Originator Lacer
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 27 Jul 2022 Lacer has been acquired by Italfarmaco
- 01 Nov 2000 Discontinued - Preclinical for Pain in Spain (unspecified route)
- 31 Aug 1998 No-Development-Reported for Pain in Spain (Unknown route)